Altre lingue Landfar Bio-medicine Co., Ltd

Azioni

000504

CNE000000263

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
7,89 ^CNY	+10,04%		+13,85%	-31,98%

29/04	Landfar Bio-medicine Co., Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
11/04	Chongqing International Trust Co., Ltd. ha acquisito una partecipazione del 10,8% in Landfar Bio-medicine Co., Ltd (SZSE:000504) da Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd per 0,03 milioni di corone norvegesi.	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Chongqing International Trust Co., Ltd. acquired 10.8% stake in Landfar Bio-medicine Co., Ltd from Shanghai Heping Dazong Equity Investment Fund Management Co., Ltd for CNY 0.03 million.	11/04
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23
Landfar Bio Medicine’s Controlling Shareholder Boosts Stake to 30%	27/04/23
Landfar Bio-medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	20/04/23
Landfar Bio-medicine Co., Ltd completed the acquisition of additional 29% stake in Hunan Nanhua Amspring Biotechnology Co., Ltd. from Wang Yang, Luo Yi and Changsha Aishi Pulin Information Consulting Co., Ltd. for CNY 9.7 million.	10/12/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/07/22
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22
NanHua Bio-medicine Co., Ltd announced that it expects to receive CNY 275.999987 million in funding from Hunan Chasing Fund Management Co., Ltd.	22/03/22
NanHua Bio-medicine Co., Ltd signed a letter of intent to acquire Medicine-related assets from YanAn Bicon Pharmaceutical Listed Company.	10/12/21
NanHua Bio-medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	30/08/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020	30/03/21
Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	28/10/20
NanHua Bio-medicine Co., Ltd's Equity Buyback announced on October 29, 2019, has expired.	28/10/20
Hunan Finance Industry Fund Management Co., Ltd. cancelled the acquisition of 25.58% stake in NanHua Bio-medicine Co., Ltd. from Hunan Trust Co., Ltd.	10/10/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Landfar Bio-medicine Co., Ltd

Azioni

000504

CNE000000263

Altre lingue

Filtri